Mannkind (MNKD) Other Non-Current Liabilities (2012 - 2026)
Mannkind (MNKD) reported Other Non-Current Liabilities of $5.1 million for Q1 2026, up 0.63% on a QoQ basis from $5.1 million in Q4 2025.
Mannkind (MNKD) has 15 years of Other Non-Current Liabilities data on file, last reported at $5.1 million in Q1 2026.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (changed N/A YoY) and the FY2025 annual result came in at $5.1 million, changed N/A from the prior year.
- Other Non-Current Liabilities climbed to $5.1 million in Q1 2026 per MNKD's latest filing, from $5.1 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $7.1 million in Q1 2022 and bottomed at $54000.0 in Q1 2023.
- The 5-year median for Other Non-Current Liabilities is $56000.0 (2022), against an average of $1.6 million.
- The widest annual swing landed in 2022, when Other Non-Current Liabilities jumped 48.41%; it then sank 99.23% in 2023.
- Tracing MNKD's Other Non-Current Liabilities over 5 years: stood at $55000.0 in 2022, then advanced by 1.82% to $56000.0 in 2023, then retreated by 1.79% to $55000.0 in 2024, then surged by 9198.18% to $5.1 million in 2025, then increased by 0.63% to $5.1 million in 2026.
- Per Business Quant, the three latest MNKD Other Non-Current Liabilities figures stand at $5.1 million (Q1 2026), $5.1 million (Q4 2025), and $55000.0 (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 5.11 Mn |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | 57,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 86,000.00 |
| Mar 31, 2022 | 7.05 Mn |
| Dec 31, 2021 | 4.95 Mn |
| Sep 30, 2021 | 286,000.00 |
| Jun 30, 2021 | 169,000.00 |
| Mar 31, 2021 | 4.75 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Sep 30, 2020 | 5.85 Mn |
| Jun 30, 2020 | 4.54 Mn |
| Mar 31, 2020 | 3.26 Mn |
| Dec 31, 2019 | 2.00 Mn |
| Jun 30, 2019 | 9.13 Mn |
| Mar 31, 2019 | 7.97 Mn |
| Dec 31, 2018 | 6.84 Mn |
| Sep 30, 2018 | 5.69 Mn |
| Jun 30, 2018 | 4.57 Mn |
| Mar 31, 2018 | 3.47 Mn |
| Dec 31, 2017 | 2.35 Mn |
| Sep 30, 2017 | 1.17 Mn |
| Jun 30, 2017 | 605,000.00 |
| Mar 31, 2017 | 10.00 Mn |
| Dec 31, 2016 | 7.38 Mn |
| Sep 30, 2016 | 17.40 Mn |
| Jun 30, 2016 | 16.67 Mn |
| Mar 31, 2016 | 15.95 Mn |
| Dec 31, 2015 | 6.38 Mn |
| Sep 30, 2015 | 14.50 Mn |
| Jun 30, 2015 | 12.12 Mn |
| Mar 31, 2015 | 26.78 Mn |
| Dec 31, 2014 | 12.30 Mn |
| Sep 30, 2014 | 11.57 Mn |
| Jun 30, 2014 | 15.04 Mn |
| Mar 31, 2014 | 14.32 Mn |
| Dec 31, 2013 | 13.61 Mn |
| Sep 30, 2013 | 20.31 Mn |
| Jun 30, 2012 | 4.92 Mn |